Natural experiments and large databases in respiratory and cardiovascular disease

by Jørgen Vestbo
Published 2016-06-01

Prevention of COPD exacerbations: medications and other controversies

by Jørgen Vestbo, Peter Lange
Published 2015-05-01

Was the implementation strategy of the ProACT trial adequately proactive?

by Alexander G. Mathioudakis, Jørgen Vestbo
Published 2019-03-01

COVID-19 and COPD: a narrative review of the basic science and clinical outcomes

by Andrew Higham, Alexander Mathioudakis, Jørgen Vestbo, Dave Singh
Published 2020-11-01

Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design

by Jørgen Vestbo, Christer Janson, Javier Nuevo, David Price
Published 2020-10-01

Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis

by Alexander G. Mathioudakis, Victoria Chatzimavridou-Grigoriadou, Alexandru Corlateanu, Jørgen Vestbo
Published 2017-02-01

Multiple flow rate modelling of nitric oxide in COPD – methodological concerns

by Kay Roy, Zoe Borrill, Andrew Hazel, Jorgen Vestbo, Dave Singh
Published 2006-12-01

Prognostic Value of C-Reactive Protein, Leukocytes, and Vitamin D in Severe Chronic Obstructive Pulmonary Disease

by Mia Moberg, Jørgen Vestbo, Gerd Martinez, Peter Lange, Thomas Ringbaek
Published 2014-01-01

The global impact of Aspergillus infection on COPD

by Emily E. Hammond, Charles S. McDonald, Jørgen Vestbo, David W. Denning
Published 2020-09-01

Supernormal lung function and risk of COPD: A contemporary population-based cohort study

by Yunus Çolak, Børge G. Nordestgaard, Peter Lange, Jørgen Vestbo, Shoaib Afzal
Published 2021-07-01

Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study

by Mette Reilev, Jesper Lykkegaard, Anders Halling, Jørgen Vestbo, Jens Søndergaard, Anton Pottegård
Published 2017-04-01

Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials

by Alexander G. Mathioudakis, Mia Moberg, Julie Janner, Pablo Alonso-Coello, Jørgen Vestbo
Published 2019-05-01

A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations

by Alexander G. Mathioudakis, Julie Janner, Mia Moberg, Pablo Alonso-Coello, Jørgen Vestbo
Published 2019-11-01

Automatic oxygen titration with O2matic® to patients admitted with COVID-19 and hypoxemic respiratory failure

by Ejvind Frausing Hansen, Charlotte Sandau Bech, Jørgen Vestbo, Ove Andersen, Linette Marie Kofod
Published 2020-01-01

Trends in smoking-related diseases by socioeconomic position following a national smoking ban in 2007: a nationwide study in the Danish population

by Nanna Schneekloth Jarlstrup, Lau C. Thygesen, Charlotta Pisinger, Jørgen Vestbo, Morten Grønbæk, Janne S. Tolstrup
Published 2023-08-01

COPD monocytes demonstrate impaired migratory ability

by Arjun K Ravi, Jonathan Plumb, Rosemary Gaskell, Sarah Mason, Caroline S Broome, George Booth, Matthew Catley, Jørgen Vestbo, Dave Singh
Published 2017-05-01

Significantly increased risk of chronic obstructive pulmonary disease amongst adults with predominantly mild congenital heart disease

by Dominic J. F. Byrne, Simon G. Williams, Apostol Nakev, Simon Frain, Stephanie L. Baross, Jørgen Vestbo, Bernard D. Keavney, David Talavera
Published 2022-11-01

Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis

by Ajmal Jabarkhil, Mia Moberg, Julie Janner, Mie Nymann Petersen, Camilla Bjørn Jensen, Lars Henrik Ängquist, Jørgen Vestbo, Tine Jess, Celeste Porsbjerg
Published 2020-01-01

Inhaled versus systemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis

by Efthymia Papadopoulou, Sulaiman Bin Safar, Ali Khalil, Jan Hansel, Ran Wang, Alexandru Corlateanu, Konstantinos Kostikas, Stavros Tryfon, Jørgen Vestbo, Alexander G. Mathioudakis
Published 2024-03-01

Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients

by Sofie Lock Johansson, Helle Wulf-Johansson, Anders Schlosser, Ingrid L. Titlestad, Bruce Miller, Ruth Tal-Singer, Uffe Holmskov, Jørgen Vestbo, Grith Lykke Sørensen
Published 2019-04-01